Niche Enzyme Portfolio BBI Enzymes specializes in manufacturing high-purity enzymes such as Glucose Oxidase and Hyaluronidase, catering specifically to diagnostic and pharmaceutical markets, which offers targeted sales opportunities in healthcare and biotech sectors.
Growth Potential With annual revenues estimated between $1M and $10M and a relatively small team, BBI Enzymes presents opportunities for scalable partnerships and collaborations to expand their product offerings or penetrate new markets.
Global Manufacturing The company operates manufacturing sites in Wales and South Africa, providing a foundation for international supply chain expansion and export strategies into larger biotech and pharmaceutical markets.
Competitive Positioning Positioned alongside similar biotech enzyme firms, BBI Enzymes can leverage its specialized product lineup and regional manufacturing advantages to differentiate itself in a competitive landscape.
Market Focus Targeting diagnostic and pharmaceutical companies, BBI Enzymes can pursue partnerships with large biotech firms seeking reliable enzyme suppliers, opening avenues for long-term B2B collaborations.
| BBI Enzymes Email Formats | Percentage |
| First.Last@bbienzymes.com | 50% |
| First.Last@bbienzymes.com | 50% |
Biotechnology ResearchWales, United Kingdom11-50 Employees
BBI Enzymes is a manufacturer of enzymes for diagnostic and pharmaceutical applications. Manufacturing sites Blaenavon, Wales (formerly Biozyme) and Cape Town, S Africa (formerly Seravac). key products include Glucose Oxidase, Horse Radish Peroxidase, Alkaline Phosphatase, Trypsin/Chymotrypsin and Hyaluronidase.
Company Overview
Funding & FinancialsBBI Enzymes's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsBBI Enzymes's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com